Explore the Global Transdermal Peptide Hormone Replacement Patches Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Transdermal Peptide Hormone Replacement Patches Market

Key Insight

FMI opines the peptide hormone replacement patch market was valued at USD 68.5 million in 2025. The industry is expected to cross USD 77.0 million in 2026 and USD 247.8 million by 2036. Parathyroid hormone analogues (abaloparatide, teriparatide, PTH 1-34) is poised to lead by Hormone type with 46.0% share in 2026 and Coated solid microneedle / solid microstructured transdermal systems is estimated to dominate by Patch technology through 2036.

March 16, 2026

Anurag Sharma

250 Pages

Cite this Report

Transdermal Peptide Hormone Replacement Patches Market

https://www.futuremarketinsights.com/reports/transdermal-peptide-hormone-replacement-patches-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Corium
Hisamitsu Pharmaceutical Co
Kindeva Drug Delivery L.P
LTS Lohmann Therapie-Systeme AG
Micron Biomedical
PharmaTher Holdings Ltd
Raphas Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Transdermal Peptide Hormone Replacement Patches Market

Key Players

Similar Industry Reports